Pharmaceuticals
Johnson & Johnson Might Need a Band-Aid Ahead of Earnings
A rally in the shares stalled around $180 in December and early January.
Bearish Bets: 3 Nasdaq Giants You Should Think About Shorting This Week
These stocks are displaying bearish tendencies based on their technical patterns.
This Small Pharma Company Could Develop Into a Nice Trade
Let's see how to trade GlycoMimetics, a clinical-stage drug developer focused on a type of cancer treatment.
Incyte Gets a Quantitative Upgrade
We have two price target areas for this biopharmaceutical firm.
As Celldex Recovers, Here's My Strategy
Let's check the charts on this clinical stage drug developer.
Moderna Shares Surge on Promising Vaccine Results
Let's check the charts and indicators.
Inflation, Crude Oil, Big Mac(ro) Attack, Tough Market, Defense Stocks, Pharma
Wednesday morning will bring traders, investors, Romans, and countrymen more macroeconomic results than they could ever wanted to peruse at one time.
How Do You Trade Pfizer If It's in a Downtrend?
Here's what the charts show.
This Pharma Presents a Potential 'Lose-Win' Situation for Patients and Investors
Two in five Americans are obese. Treatments that target obesity directly could be the next blockbuster pharma category.
Walgreens Could Continue to Weaken
The company reported earnings and the shares have rolled over and turned down.